Bio Pharma Dive
FEBRUARY 5, 2021
Delays tied to factory inspections had pushed an FDA decision on Breyanzi past a key deadline, allowing Bristol Myers to avoid paying billions of dollars in payouts to investors.
World of DTC Marketing
FEBRUARY 5, 2021
SUMMARY: The number of visitors to your website doesn’t mean anything if you have high bounce rates and low page views/time on site. More than half of mobile users leave a website that takes more than three seconds to load, yet too many pharma sites are not optimized for mobile. Houston, we have a problem. Attention spans online are declining rapidly.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Times
FEBRUARY 1, 2021
Research led by the University of East Anglia in collaboration Boots UK and Leiden University
pharmaphorum
FEBRUARY 4, 2021
A white paper has outlined a pathway that could allow Italy to realise the potential of digital therapeutics (DTx). The official journal of the Smith Kline Foundation, Tendenze Nuove, has published the paper entitled “Digital Therapeutics, an Opportunity for Italy” earlier this month. The book features insights and recommendations from 40 leading experts in the field, who hope that Italy will begin to follow in the footsteps of early adopters of digital therapeutics such as Germany, France and
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Bio Pharma Dive
FEBRUARY 1, 2021
Gritstone Oncology, known for its cancer research, is drawing attention in infectious disease, signing a deal with Gilead two weeks after announcing plans to develop a coronavirus vaccine.
World of DTC Marketing
FEBRUARY 3, 2021
SUMMARY: The biggest threat to the pharma industry isn’t the coming tsunami of healthcare changes. It’s reshaping the company to once again focus on patients instead of profits. At the end of last year, I worked with a leading cancer company on a test program that involved an email program. We started with research to uncover the needs and wants of current cancer patients (NSC lung) and caregivers.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
pharmaphorum
FEBRUARY 5, 2021
Over the last year, we’ve noticed that “connectivity” doesn’t always equate to “connected” – and that’s just as true in the realm of clinical trials as it is in our personal lives. Amanda Barrell reports from a panel at the Patients as Partners Europe conference on remote clinical trials. Decentralised trials have been growing in popularity in recent years, and the COVID-19 pandemic has served to accelerate that progress.
Bio Pharma Dive
FEBRUARY 3, 2021
While the biotech prepares to launch aducanumab, its latest earnings report shows significant hits to top-selling drugs, plus another pipeline failure.
World of DTC Marketing
FEBRUARY 1, 2021
SUMMARY: Digital ad spend in pharmaceutical brands is up 111% so far in 2020 and 80% of that money is being thrown away by fraud and the popularity of programmatic advertising. While popular, digital advertising wasn’t an immediate hit in the pharmaceuticals arena due to the strict regulations. Pharmaceutical advertisers have traditionally been slow to join with the latest trends simply because it’s more complicated for regulated industries.
Pharma Times
FEBRUARY 3, 2021
Final guidance on the drug's use to treat patients with severe eosinophilic asthma on the NHS has now been published
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharma Mirror
FEBRUARY 4, 2021
Olympus Corporation (Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi) announced today that it has been selected(1) by Japan’s Ministry of Health, Labour and Welfare (MHLW) to implement the Japan-Russia Medical Cooperation Promotion Project in the field of endoscopy for the fiscal year ending March, 2021. Under the project, Olympus will promulgate gastrointestinal endoscopic/laparoscopic techniques in support of a five-year oncology plan launched by the Russian
Bio Pharma Dive
FEBRUARY 1, 2021
Already a partner on the shot's development, Bayer will chip in on manufacturing too, pledging to make 160 million doses in 2022.
World of DTC Marketing
JANUARY 31, 2021
SUMMARY: “How big pharma takeovers destroy innovation” a report from Congresswoman Porter does make some points. Still, she is missing a lot of facts at a time when hospital and health insurance costs are soaring. I always have pointed instances in which pharma puts Wall Street first and patients second. Ms. Porter points out that R&D seems to have been replaced with mergers and acquisitions, but she misses the big picture by focusing solely on drug costs.
Pharma Times
FEBRUARY 1, 2021
Bumper meeting saw 13 new medicines recommended for approval
Pharma Mirror
FEBRUARY 4, 2021
The American Dream is why the United States is considered the “land of opportunity,” and why for centuries immigrants have flocked to our shores seeking their fortunes. Guo-Liang Yu, Ph.D., (China), and Sanjeev Redkar, Ph.D., (India), came to the U.S. in the 1980s. By anyone’s reasonable measure, both have achieved the American Dream.
Bio Pharma Dive
FEBRUARY 4, 2021
With J&J's application filed, the FDA will start reviewing study results which the company says show its shot to be 66% effective against moderate or severe COVID-19.
World of DTC Marketing
FEBRUARY 4, 2021
SUMMARY: The industry is facing several challenges on several fronts. Amgen is laying off people because of their poor financial outlook. Merck’s old drugs are under more scrutiny, and anti-vaxxers are causing problems by cherry-picking unreliable information. Amgen announced that it’s laying off a significant number of people, most from the salesforce, under the guise that they’re going “digital.” Let’s be honest: this is a way to inflate a company’s st
Pharma Times
FEBRUARY 4, 2021
Projects will investigate immune checkpoints and contribute to the development of new cancer treatments
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharma Mirror
FEBRUARY 4, 2021
Ensuring punches and dies are kept in optimum condition is essential to produce high quality tablets. As the demand for pharmaceutical tablets increases, the importance for proficient tool maintenance becomes even more important. To help companies understand the processes involved, I Holland, leaders in the manufacture of tablet tooling, will launch a free seven month webinar series, with the first presentation taking place at 2pm GMT on 25th February 2021.
Bio Pharma Dive
FEBRUARY 3, 2021
Nine other drug developers are set to price initial public offerings this week, extending a record run of financing activity from last year. Sana's is one of the largest in history.
World of DTC Marketing
FEBRUARY 1, 2021
SUMMARY: The biggest argument against pharma is the cost of prescription drugs. Pharma could do something about this by simply uniting to make it easier for patients who can’t afford their medications to get them free or at little cost. OK, I will be the first to admit that pharma has problems and has not put patients first, but the reality is that the pharmaceutical industry is a business.
Outsourcing Pharma
FEBRUARY 4, 2021
The founder of Andaman7âs leukemia diagnosis, and his sonâs experience with bone cancer, have helped inform the firm's tech and patient-centric approach.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Pharma Mirror
FEBRUARY 4, 2021
Olympus Corporation (Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi) announced today that it has been selected(1) by Japan’s Ministry of Health, Labour and Welfare (MHLW) to implement the Japan-Russia Medical Cooperation Promotion Project in the field of endoscopy for the fiscal year ending March, 2021. Under the project, Olympus will promulgate gastrointestinal endoscopic/laparoscopic techniques in support of a five-year oncology plan launched by the Russian
Bio Pharma Dive
FEBRUARY 4, 2021
Frazier, who's retiring after a three-decade career at Merck, will hand the reins to CFO Robert Davis at the end of June. While Frazier's tenure was framed by the success of Keytruda, his leadership extended far beyond Merck's walls.
World of DTC Marketing
FEBRUARY 2, 2021
SUMMARY : DigitalHealth.com, a British website, had a fascinating look at the use of health apps during the pandemic. Among their findings: Downloads of apps supporting consumers with mental health needs increased by nearly 200% from summer 2019 to summer 2020 Downloads of those supporting consumers with diets and weight loss rose by a massive 1294% from mid-2019 to mid-2020.
NY Times
FEBRUARY 3, 2021
The consulting firm has reached the agreement with 47 states because of its advice to drugmakers, including Purdue Pharma, the manufacturer of OxyContin.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
pharmaphorum
FEBRUARY 1, 2021
It’s well recognised that people with psoriasis can develop depression or anxiety, particularly in moderate or severe cases where a sizeable part of the body can have skin lesions. Now, drugmaker Almirall and digital health firm Happify are working on a tool to support mental health in these patients. Almirall is a specialist in psoriasis therapies with drugs like Skilarence (dimethyl fumarate) and Ilumetri (tildrakizumab), while Happify’s app is designed to drive away negative thoughts through
Bio Pharma Dive
FEBRUARY 5, 2021
Sales of the antiviral drug accounted for a quarter of the biotech's product revenue in the fourth quarter, disguising hits to its business elsewhere.
Pharma Times
FEBRUARY 5, 2021
Jab recently demonstrated 89.
XTalks
FEBRUARY 5, 2021
As COVID-19 vaccines continue to be in short supply around the world, pharma giants such as Bayer (Nasdaq: BAYRY ) are stepping up to help fulfill the need. Bayer has agreed to assist in the manufacturing of an mRNA-based coronavirus vaccine, CVnCOV, developed by fellow German biopharma company CureVac (Nasdaq: CVAC ). In early January, Bayer also struck an agreement with the company to support the further development, supply and key territory operations of CureVac’s COVID-19 vaccine candidate.
Expert insights. Personalized for you.
360 
Let's personalize your content